ADVM (Adverum Biotechnologies Inc.) Aset Bersih Perusahaan

The asset value of Adverum Biotechnologies (ADVM) tracked on this chart stands at -0.06. The business relies on external contractors for testing and vector production. Due to the absence of commercial products, research costs are creating negative operating leverage. Meanwhile, Adverum Biotechnologies (ADVM) acts as a bioengineering pioneer, developing single-injection therapies to restore vision in cases of genetic pathologies.

ADVM Kapitalisasi Buku Adverum Biotechnologies, Inc. (04.07.2022 - 20.12.2025)

Rincian metrik lan analitis perusahaan Adverum (ADVM)

- rega lan prakiraan konsensus rega:

Bagan rega Adverum Biotechnologies|ADVM - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Adverum Biotechnologies Inc.|ADVM - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham Adverum Biotechnologies|ADVM - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku adverum.com|ADVM - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Adverum Biotechnologies|ADVM - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Adverum Biotechnologies|ADVM - Utang perusahaan|Utang marang nilai buku Adverum Biotechnologies Inc.|ADVM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adverum Biotechnologies

Pambiji fundamental:ADVM - Adverum Biotechnologies, Inc.

Book value determines the residual value of net assets minus all liabilities, reflecting the shareholders' actual internal resources. This metric allows for an assessment of the financial resilience of Adverum Biotechnologies (ADVM) against supply chain disruptions and patent risks, making the company's balance sheet equity history a critical tool for avoiding overpayment for the asset.

Analisis pesaing Adverum Biotechnologies